vs

Side-by-side financial comparison of Armada Hoffler Properties, Inc. (AHH) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

Armada Hoffler Properties, Inc. is the larger business by last-quarter revenue ($75.6M vs $75.5M, roughly 1.0× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 0.8%). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -22.8%).

Armada Hoffler Properties, Inc. is a publicly traded U.S. real estate investment trust operating across the Mid-Atlantic and Southeast regions. It develops, owns, and manages a diversified portfolio of office, retail, and multifamily residential properties, and also offers construction and development services for third-party clients.

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

AHH vs PBYI — Head-to-Head

Bigger by revenue
AHH
AHH
1.0× larger
AHH
$75.6M
$75.5M
PBYI
Growing faster (revenue YoY)
PBYI
PBYI
+26.9% gap
PBYI
27.7%
0.8%
AHH
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
-22.8%
AHH

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AHH
AHH
PBYI
PBYI
Revenue
$75.6M
$75.5M
Net Profit
$2.4M
Gross Margin
69.3%
Operating Margin
31.0%
22.7%
Net Margin
3.1%
Revenue YoY
0.8%
27.7%
Net Profit YoY
-89.8%
EPS (diluted)
$0.00
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AHH
AHH
PBYI
PBYI
Q4 25
$75.6M
$75.5M
Q3 25
$72.7M
$54.5M
Q2 25
$69.1M
$52.4M
Q1 25
$67.8M
$46.0M
Q4 24
$75.0M
$59.1M
Q3 24
$114.4M
$80.5M
Q2 24
$116.8M
$47.1M
Q1 24
$127.0M
$43.8M
Net Profit
AHH
AHH
PBYI
PBYI
Q4 25
$2.4M
Q3 25
$80.0K
$8.8M
Q2 25
$5.9M
$5.9M
Q1 25
$-2.8M
$3.0M
Q4 24
$23.4M
Q3 24
$-5.0M
$20.3M
Q2 24
$3.2M
$-4.5M
Q1 24
$14.1M
$-4.8M
Gross Margin
AHH
AHH
PBYI
PBYI
Q4 25
69.3%
Q3 25
77.7%
Q2 25
76.5%
Q1 25
77.1%
Q4 24
76.4%
Q3 24
45.0%
63.9%
Q2 24
41.8%
77.4%
Q1 24
37.9%
75.5%
Operating Margin
AHH
AHH
PBYI
PBYI
Q4 25
31.0%
22.7%
Q3 25
29.2%
17.6%
Q2 25
29.6%
12.7%
Q1 25
23.2%
8.7%
Q4 24
50.1%
22.6%
Q3 24
19.0%
27.4%
Q2 24
11.9%
-4.6%
Q1 24
15.1%
-5.3%
Net Margin
AHH
AHH
PBYI
PBYI
Q4 25
3.1%
Q3 25
0.1%
16.2%
Q2 25
8.6%
11.2%
Q1 25
-4.1%
6.5%
Q4 24
31.2%
Q3 24
-4.4%
25.2%
Q2 24
2.7%
-9.6%
Q1 24
11.1%
-11.0%
EPS (diluted)
AHH
AHH
PBYI
PBYI
Q4 25
$0.00
$0.26
Q3 25
$-0.04
$0.17
Q2 25
$0.04
$0.12
Q1 25
$-0.07
$0.06
Q4 24
$0.28
$0.40
Q3 24
$-0.11
$0.41
Q2 24
$0.00
$-0.09
Q1 24
$0.17
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AHH
AHH
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$49.1M
$97.5M
Total DebtLower is stronger
$1.5B
$22.7M
Stockholders' EquityBook value
$627.8M
$130.3M
Total Assets
$2.6B
$216.3M
Debt / EquityLower = less leverage
2.43×
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AHH
AHH
PBYI
PBYI
Q4 25
$49.1M
$97.5M
Q3 25
$46.5M
$94.4M
Q2 25
$52.1M
$96.0M
Q1 25
$45.7M
$93.2M
Q4 24
$31.9M
$101.0M
Q3 24
$43.9M
$96.7M
Q2 24
$20.3M
$96.8M
Q1 24
$41.9M
$107.2M
Total Debt
AHH
AHH
PBYI
PBYI
Q4 25
$1.5B
$22.7M
Q3 25
$1.5B
$34.0M
Q2 25
$1.4B
$45.3M
Q1 25
$1.3B
$56.7M
Q4 24
$1.3B
$68.0M
Q3 24
$1.3B
$79.3M
Q2 24
$1.4B
$90.7M
Q1 24
$1.4B
$102.0M
Stockholders' Equity
AHH
AHH
PBYI
PBYI
Q4 25
$627.8M
$130.3M
Q3 25
$638.8M
$115.3M
Q2 25
$652.0M
$104.7M
Q1 25
$657.4M
$97.1M
Q4 24
$670.6M
$92.1M
Q3 24
$663.9M
$71.1M
Q2 24
$562.7M
$48.5M
Q1 24
$571.4M
$51.0M
Total Assets
AHH
AHH
PBYI
PBYI
Q4 25
$2.6B
$216.3M
Q3 25
$2.6B
$202.9M
Q2 25
$2.6B
$194.9M
Q1 25
$2.5B
$196.2M
Q4 24
$2.5B
$213.3M
Q3 24
$2.6B
$220.7M
Q2 24
$2.6B
$205.0M
Q1 24
$2.6B
$214.1M
Debt / Equity
AHH
AHH
PBYI
PBYI
Q4 25
2.43×
0.17×
Q3 25
2.33×
0.30×
Q2 25
2.22×
0.43×
Q1 25
2.01×
0.58×
Q4 24
1.93×
0.74×
Q3 24
2.00×
1.12×
Q2 24
2.52×
1.87×
Q1 24
2.50×
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AHH
AHH
PBYI
PBYI
Operating Cash FlowLast quarter
$64.2M
$14.4M
Free Cash FlowOCF − Capex
$14.4M
FCF MarginFCF / Revenue
19.1%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
26.99×
TTM Free Cash FlowTrailing 4 quarters
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AHH
AHH
PBYI
PBYI
Q4 25
$64.2M
$14.4M
Q3 25
$26.3M
$9.7M
Q2 25
$11.1M
$14.1M
Q1 25
$107.0K
$3.6M
Q4 24
$112.0M
$15.6M
Q3 24
$27.3M
$11.0M
Q2 24
$17.4M
$1.0M
Q1 24
$46.5M
$11.2M
Free Cash Flow
AHH
AHH
PBYI
PBYI
Q4 25
$14.4M
Q3 25
$9.7M
Q2 25
$14.1M
Q1 25
$3.6M
Q4 24
$15.6M
Q3 24
$11.0M
Q2 24
$1.0M
Q1 24
FCF Margin
AHH
AHH
PBYI
PBYI
Q4 25
19.1%
Q3 25
17.7%
Q2 25
26.8%
Q1 25
7.7%
Q4 24
26.4%
Q3 24
13.7%
Q2 24
2.1%
Q1 24
Capex Intensity
AHH
AHH
PBYI
PBYI
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
0.1%
Q4 24
0.0%
Q3 24
0.0%
Q2 24
0.0%
Q1 24
0.0%
Cash Conversion
AHH
AHH
PBYI
PBYI
Q4 25
26.99×
Q3 25
328.63×
1.10×
Q2 25
1.87×
2.41×
Q1 25
1.21×
Q4 24
4.78×
Q3 24
0.54×
Q2 24
5.48×
Q1 24
3.30×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AHH
AHH

Office Real Estate Segment$28.8M38%
Retail Real Estate Segment$25.4M34%
Multifamily Residential Real Estate$17.7M23%
Real Estate Financing Segment$3.6M5%

PBYI
PBYI

Segment breakdown not available.

Related Comparisons